Intracochlear Application of VSF1.01 for the Reduction of Cochlear Implant Surgery Related Trauma

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 18, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Hearing Loss
Interventions
DRUG

Intracochlear application of VSF1.01

During cochlear implant operation, patients receive intracochlear VSF1.01 prior to insertion of the electrode array.

Trial Locations (1)

30625

RECRUITING

Hannover Medical School, Dept. of Otorhinolaryngology, Hanover

All Listed Sponsors
lead

Hannover Medical School

OTHER